SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-019780
Filing Date
2018-04-09
Accepted
2018-04-09 16:14:12
Documents
6
Period of Report
2018-04-27
Effectiveness Date
2018-04-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv490474-def14a.htm DEF 14A 146726
2 GRAPHIC lg_georgeson.jpg GRAPHIC 23002
3 GRAPHIC tv490474_proxy1.jpg GRAPHIC 238423
4 GRAPHIC tv490474_proxy2.jpg GRAPHIC 175752
5 GRAPHIC tv490474_proxy3.jpg GRAPHIC 223518
6 GRAPHIC tv490474_proxy4.jpg GRAPHIC 165610
  Complete submission text file 0001144204-18-019780.txt   1286472
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35737 | Film No.: 18745725
SIC: 2834 Pharmaceutical Preparations